Covid-19: ecig only add 1% of risk compared to breathing

Incredibly, people close to an infected vaper using an e-cigarette in home or restaurant scenarios face a one percent increase of risk of contagion compared to the control case of a normal breathing (without vaping) inside closed spaces. This relative added risk becomes 5-17 percent for high intensity vaping and up to 260 percent for speaking for various periods and coughing.

Continue ReadingCovid-19: ecig only add 1% of risk compared to breathing

US: end of teen nicotine vaping epidemic and eradication of tobacco smoking

The use of e-cigarette among teenagers in the United States is considered a significant public health problem. A close look at federal data now show that the number of young e-cigarette users has markedly declined to below epidemic levels since its peak in 2019.

Continue ReadingUS: end of teen nicotine vaping epidemic and eradication of tobacco smoking

The first review to assess the metabolic impact of stopping smoking in patients with diabetes mellitus revealed serious gaps in the literature

Quitting smoking can reduce cardiovascular and kidney failure risks. However, it can lead to side effects such as weight gain. A scoping review conducted by a pool of European researchers revealed a lack of data on the metabolic effects of smoking and smoking cessation in diabetes. Healthcare professionals should not assume that cessation of smoking will improve metabolic parameters in patients with diabetes.

Continue ReadingThe first review to assess the metabolic impact of stopping smoking in patients with diabetes mellitus revealed serious gaps in the literature

CoEHAR and ANPVU to Commissioner Kyriakides: ecig as aids for smoking cessation

Prof. Riccardo Polosa, Founder of the CoEHAR, and Carmine Canino, President of  ANPVU, National Association of ecig consumers, have sent a letter to the European Commissioner for Health Stella Kyriakides, regarding her statements on the effectiveness of e-cigarettes to quit smoking.

Continue ReadingCoEHAR and ANPVU to Commissioner Kyriakides: ecig as aids for smoking cessation
Read more about the article Experimental Biology 2022: CoEHAR flies to Philadelphia to present the Replica project
alfio distefano experimental biology

Experimental Biology 2022: CoEHAR flies to Philadelphia to present the Replica project

CoEHAR presented the results of the Replica project during Experimental Biology 2022, the annual meeting that brings together thousands of scientists and experts in the field of anatomy, biochemistry and molecular biology, investigative pathology, pharmacology, and physiology. Representing CoEHAR, the researcher Alfio Distefano, PhD student in neuroscience at the University of Catania

Continue ReadingExperimental Biology 2022: CoEHAR flies to Philadelphia to present the Replica project

International validation of CoEHAR studies: fewer Covid-19 hospitalization among smokers and studies on the role of nicotine

Direct causal relationship between smoking and COVID-19 outcomes: the work of CoEHAR researchers finds confirmations in an english cohort study. Compared with people who had never smoked, current smoking was associated with one-third lower risk of hospitalization

Continue ReadingInternational validation of CoEHAR studies: fewer Covid-19 hospitalization among smokers and studies on the role of nicotine